Spiro George Rombotis - 18 Nov 2021 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
President and CEO, Director
Signature
/s/ Spiro Rombotis
Issuer symbol
CYCC
Transactions as of
18 Nov 2021
Net transactions value
+$18,000
Form type
4
Filing time
22 Nov 2021, 15:05:55 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCC Common Stock Purchase $18,000 +4,000 +405% $4.50 4,988 18 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased 4,000 shares of common stock on November 18, 2021.